The UDENTG provides coverage for approximately 850,000 inhabitants of the Girona demarcation through an integrated care network that includes the Dr. Josep Trueta University Hospital of Girona, the Santa Caterina Hospital in Salt, the comarcal hospitals of Blanes, Figueres, Palamós, Olot, and Campdevànol, and 31 primary care areas.
Established in 1996 and reorganized in 2006 with a territorial vision, the Unit maintains a first-visit accessibility rate of 94%, despite a per capita demand higher than the Catalan average. This success is based on decentralized care, with 60% of first visits taking place in comarcal hospitals, and close coordination with primary care through over 100 weekly non-face-to-face consultations.
In 2025, the Unit attended 12,907 patients at the Trueta and Santa Caterina hospitals alone, complemented by care at the comarcal hospitals. The head of the Endocrinology Service at Trueta Hospital, Mercè Fernández-Balsells, emphasizes that the territorial vision has become a consolidated reality and a reference model.
With over 19,000 annual visits (including initial, follow-up, and remote consultations), the UDENTG has a multidisciplinary team of 15 specialists, 6 dietitians-nutritionists, and 6 diabetes nurse educators. Since 2002, it has been accredited as a specialized healthcare training unit (MIR) and collaborates with the Faculty of Medicine at the University of Girona (UdG).
The Endocrinology and Diabetes Day Hospital, celebrating its 25th anniversary, has reduced hospitalizations by 80% in ten years. While 287 annual hospitalizations were recorded in 1997, currently there are fewer than 50. In 2016, 44 admissions were registered, and by October 2026, only 9. This resource serves over 2,000 patients annually.
On the occasion of World Diabetes Day (November 14th), the Unit highlights its commitment to technological innovation in type 1 diabetes, with over 90% of patients using continuous glucose monitoring systems and approximately 250 patients being monitored with hybrid automated insulin delivery systems.
The UDENTG is also a reference in managing complex obesity (nearly 800 patients in follow-up) and thyroid cancer (around 1,000 patients under control), offering comprehensive and personalized care.
